"If we cannot protect the U.S. commitment to global health spending, every single program in global health is going to have to chop, chop, chop its budget." With this statement, Laurie Garrett, senior fellow for global health at the Council on Foreign Relations and the moderator of Research!America's forum, "Global Health Research and Development in New York: Fueling Innovation and Saving Lives," set the tone of discussion and provided a call to action to the New York global health community.
Mary Woolley, president and CEO of Research!America, and Rep. Nita Lowey(D-NY), opened the forumâheld in April at the New York Academyof Sciencesâby acknowledging the remarkable progress made in global health R&D in the past decade and the significant impact that this work has had on New York's economy.
Garrett then moderated a discussion among expert panelists Rachel Cohen, regional executive director, Drugs for Neglected Diseases initiative North America; Jack DeHovitz,MD, MPH, director, SUNY Downstate AIDS International Training and Research Program; Margaret McGlynn, president and CEO, International AIDS Vaccine Initiative; Mel Spigelman,MD, president and CEO, Global Alliance for TB Drug Development; and Pol Vandenbroucke, MD, vice president of development, emerging markets, Pfizer. In addition to discussing potential consequences of the proposed funding cuts to global health programs in the president's FY13 budget request, panelists also talked about the role of public-private partnerships in sustaining the momentum of progress in global health R&D in New York.